# Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/empagliflozin-normalizes-the-size-and-number-of-mitochondria-and-prevents/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Masashi Mizuno,Atsushi Kuno,Toshiyuki Yano,Takayuki Miki,H Oshima,Tatsuya Sato,Kei Nakata,Yukishige Kimura,Masaya Tanno,Tetsuji Miura |
| Citations | 170 |
| DOI | 10.14814/phy2.13741 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.14814/phy2.13741 |
| OpenAlex ID | https://openalex.org/W2808816873 |
| PMID | 29932506 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Masashi Mizuno](https://scholariq.org/researchers/masashi-mizuno/)

## Paper primary topic

- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

## Paper topics

- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.